SCHEMBL21758841

SCHEMBL21758841

C=C(CO)N1CCC(c2c[nH]c3cc(C)ccc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
BRD4 O60885 1/20 0.48
ALDH1A1 P00352 1/20 0.48
POLB P06746 1/20 0.48
CREBBP Q92793 1/20 0.48
DRD2 P14416 4/20 0.47
SLC6A4 P31645 1/20 0.47
APP P05067 3/20 0.45
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
THPO P40225 1/20 0.43
ADRA1D P25100 2/20 0.43
IDO1 P14902 1/20 0.43
HTR2A P28223 3/20 0.41
HTR7 P34969 3/20 0.41
KCNH2 Q12809 3/20 0.41
HTR1D P28221 2/20 0.41
HTR1B P28222 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23010845 0.80 APP (0.64) KDM4EDRD2SLC6A4APPCYP1A2
SCHEMBL21758401 0.78 CYP1A2 (0.54) KDM4EBRD4ALDH1A1POLBCREBBP
SCHEMBL12367411 0.77 IDO1 (0.54) DRD2SLC6A4APPADRA1DIDO1
SCHEMBL8106285 0.76 KDM4E (0.61) KDM4EBRD4ALDH1A1POLBCREBBP
SCHEMBL21758421 0.76 DRD2 (0.69) KDM4EBRD4ALDH1A1POLBCREBBP
SCHEMBL4676876 0.76 IDO1 (0.50) DRD2SLC6A4APPADRA1DIDO1
SCHEMBL18324794 0.75 IDO1 (0.47) KDM4EBRD4ALDH1A1POLBCREBBP
SCHEMBL12367426 0.74 IDO1 (0.51) DRD2SLC6A4APPADRA1DIDO1
SCHEMBL4676883 0.74 HTR2C (0.62) DRD2SLC6A4APPIDO1HTR2A
SCHEMBL16801602 0.72 KDM4E (0.70) KDM4EBRD4ALDH1A1POLBCREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3082802-B1 TRYPTOPHAN-2,3-DIOXYGENASE (TDO) AND/OR INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS AND THEIR USE IOMET PHARMA LTD (GB) 2020-02-26 EP disclosed